Skip to main content

Table 7 The analysis results of the compliance rates (STEP II)

From: Clinical characteristics and satisfaction with the fimasartan in Korean hypertensive patients: a prospective, cross-sectional and open-label, 8-week switching study (Kanarb-hypertension epidemiology medication satisfaction study; K-HEMS study)

Total Scores

Baseline

4 weeks

8 weeks

(N = 2021)

(N = 1919)

(N = 1818)

Motivation

 Mean ± SD

2.3 ± 1.0

2.6 ± 0.7

2.7 ± 0.6

 Low (0~ 1), n (%)

401 (19.84)

160 (8.34)

119 (6.55)

 High (2~ 3), n (%)

1620 (80.16)

1759 (91.66)

1699 (93.45)

p-value

 

< 0.0001

< 0.0001

Knowledge

 Mean ± SD

2.4 ± 0.7

2.5 ± 0.6

2.6 ± 0.6

 Low (0~ 1), n (%)

205 (10.14)

122 (6.36)

79 (4.35)

 High (2~ 3), n (%)

1817 (89.86)

1797 (93.64)

1739 (95.65)

p-value

 

< 0.0001

< 0.0001

  1. Tested by McNemar test